NeuroSense Therapeutics Ltd.
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$10,107,000 over the previous period. Total operating expenses were $10,285,000.
Profit Margin
| 2019 | 0 | -1.22M | |
|---|---|---|---|
| 2020 | 0 | -2.82M | |
| 2021 | 0 | -2.49M | |
| 2022 | 0 | -11.19M | |
| 2023 | 0 | -10.10M |
NRSN Income Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Revenue | |||||
Revenue | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 97K | 89K | 3K | 3K | 0 |
Gross profit | -97K | -89K | -3K | -3K | 0 |
Operating exp. | |||||
Research and development | 7.27M | 6.41M | 3.08M | 2.49M | 898K |
Selling and marketing | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 10.28M | 13.55M | 5.58M | 2.88M | 1.23M |
Operating income | -12.04M | -13.55M | -5.58M | -2.88M | -1.23M |
Other income (expenses), net | 769K | 1.21M | 1.54M | 60K | 13K |
Income before tax | -11.28M | -12.34M | -4.04M | -2.82M | -1.22M |
Income tax expense | 0 | -1.14M | -1.54M | 1K | 5K |
Net income | -10.10M | -11.19M | -2.49M | -2.82M | -1.22M |
Earnings per share | |||||
Basic EPS | -0.83 | -0.97 | -1.29 | -1.46 | -0.63 |
Diluted EPS | -0.83 | -0.97 | -1.29 | -1.46 | -0.63 |
| Data source | Data source | Data source |